BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 11312420)

  • 1. The risk of melanoma in association with long-term exposure to PUVA.
    Stern RS;
    J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
    Stern RS; Nichols KT; Väkevä LH
    N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS
    Blood Cells; 1992; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS;
    J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study.
    Malanos D; Stern RS
    J Am Acad Dermatol; 2007 Aug; 57(2):231-7. PubMed ID: 17532094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
    Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
    Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
    Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
    Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis.
    Stern RS; Lange R
    Arch Dermatol; 1991 Mar; 127(3):347-50. PubMed ID: 1998364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous melanomas in patients treated with psoralens plus ultraviolet A. A case report and the experience of the PUVA Follow-up Study.
    Gupta AK; Stern RS; Swanson NA; Anderson TF
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):67-76. PubMed ID: 3403747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoma risk in psoriasis: results of the PUVA follow-up study.
    Stern RS
    Arch Dermatol; 2006 Sep; 142(9):1132-5. PubMed ID: 16983000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
    N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
    Henseler T; Christophers E
    Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
    Takashima A; Matsunami E; Yamamoto K; Kitajima S; Mizuno N
    Photodermatol Photoimmunol Photomed; 1990 Oct; 7(5):218-21. PubMed ID: 2091746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study.
    Stern RS
    N Engl J Med; 1990 Apr; 322(16):1093-7. PubMed ID: 2320078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Puva therapy and carcinogenesis].
    Thomas P; Pannequin C
    Ann Dermatol Venereol; 1991; 118(6-7):503-6. PubMed ID: 1897842
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PUVA and cancer risk: the Swedish follow-up study.
    Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Johannesson A; Berne B; Ljunggren B; Andersson T; Molin L; Nylander-Lundqvist E; Emtestam L
    Br J Dermatol; 1999 Jul; 141(1):108-12. PubMed ID: 10417523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term effects of PUVA therapy on Israeli patients with vitiligo].
    Vussuki E; Ziv M; Rosenman D; David M
    Harefuah; 2006 Jul; 145(7):483-5, 552, 551. PubMed ID: 16900734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis.
    Dayal S; ; Jain VK
    Indian J Dermatol Venereol Leprol; 2010; 76(5):533-7. PubMed ID: 20826993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
    Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.